Literature DB >> 15361386

Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis.

Y Allanore1, C Parc, D Monnet, A P Brézin, A Kahan.   

Abstract

BACKGROUND: Cardiovascular diseases, vasospasm, and dysimmunity have been implicated in normal tension glaucoma (NTG).
OBJECTIVE: To investigate the prevalence of ocular abnormalities suggestive of glaucoma damage in systemic sclerosis (SSc).
METHODS: 61 patients with SSc (mean (SD) age 56.2 (12) years, mean (SD) disease duration 9.9 (9) years; 41 with limited cutaneous disease) and 37 control subjects with osteoarthritis (mean (SD) age 55.9 (12) years) were studied. They were systematically referred to an ophthalmologist. The evaluation was based on aplanation tonometry, ophthalmoscopy with retinal photography (evaluation of cup/disc ratio (c/d)), and automated static perimetry (determination of mean defects (MD)). Statistical analyses were performed with the chi(2), Mann-Whitney, and Spearman tests.
RESULTS: The mean visual acuity and intraocular pressure were similar in both groups. An excavation with a c/d >0.3 was found in 27 eyes from patients with SSc and 5 eyes from controls (p = 0.009); a c/d >0.7 was found in 4 eyes from patients with SSc and none in the controls (NS). Visual field defects (MD <-2 dB) were found in 55 eyes from patients with SSc and in 18 eyes from controls (p<0.0001). A concomitant c/d >0.3 and MD <-2 dB was found in 21 eyes from 12 patients with SSc but in none of the control eyes (p<0.0001).
CONCLUSION: Ocular abnormalities suggesting glaucomatous neuropathy without ocular hypertension were dramatically more prevalent in patients with SSc. These abnormalities seem to be mild but justify long term follow up. They are consistent with the vascular pathogenic hypothesis for NTG.

Entities:  

Mesh:

Year:  2004        PMID: 15361386      PMCID: PMC1754752          DOI: 10.1136/ard.2003.013540

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Immune-related disease and normal-tension glaucoma. A case-control study.

Authors:  M J Cartwright; A L Grajewski; M L Friedberg; D R Anderson; D W Richards
Journal:  Arch Ophthalmol       Date:  1992-04

Review 2.  Glaucomatous optic neuropathy.

Authors:  E M Van Buskirk; G A Cioffi
Journal:  Am J Ophthalmol       Date:  1992-04-15       Impact factor: 5.258

3.  Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma.

Authors:  M B Wax; G Tezel; I Saito; R S Gupta; J B Harley; Z Li; C Romano
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

4.  Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans.

Authors:  K Strenn; B Matulla; M Wolzt; O Findl; M C Bekes; U Lamsfuss; U Graselli; G Rainer; R Menapace; H G Eichler; L Schmetterer
Journal:  Clin Pharmacol Ther       Date:  1998-01       Impact factor: 6.875

Review 5.  Open-angle glaucoma.

Authors:  H A Quigley
Journal:  N Engl J Med       Date:  1993-04-15       Impact factor: 91.245

Review 6.  Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.

Authors:  B Kahaleh; M Matucci-Cerinic
Journal:  Arthritis Rheum       Date:  1995-01

7.  Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases.

Authors:  T Yamamoto; M Maeda; A Sawada; K Sugiyama; T Taniguchi; Y Kitazawa; Z Oyama; N Ichihashi; H Takagi; Y Kitajima
Journal:  Jpn J Ophthalmol       Date:  1999 Nov-Dec       Impact factor: 2.447

8.  Migraine and glaucoma: an epidemiologic survey of French ophthalmologists.

Authors:  A Pradalier; P Hamard; E Sellem; L Bringer
Journal:  Cephalalgia       Date:  1998-03       Impact factor: 6.292

9.  Glaucoma and vasospasm.

Authors:  D C Broadway; S M Drance
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies.

Authors:  T Sugiyama; S Moriya; H Oku; I Azuma
Journal:  Surv Ophthalmol       Date:  1995-05       Impact factor: 6.048

View more
  10 in total

1.  A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy.

Authors:  Huseyin Mayali; Muhammed Altinisik; Secil Sencan; Timur Pirildar; Emin Kurt
Journal:  Int Ophthalmol       Date:  2019-09-28       Impact factor: 2.031

2.  Comment on 'Evaluation of choroidal thickness in patients with scleroderma'.

Authors:  S Uzun
Journal:  Eye (Lond)       Date:  2016-05-20       Impact factor: 3.775

3.  Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

Authors:  Beatriz Fiuza Gomes; Rebeca Souza; Thiago Valadão; Newton Kara-Junior; Haroldo Vieira Moraes; Marcony R Santhiago
Journal:  Int Ophthalmol       Date:  2017-05-06       Impact factor: 2.031

4.  Structural abnormalities associated with glaucoma using swept-source optical coherence tomography in patients with systemic sclerosis.

Authors:  Cecilia Victoria Agapito Tito; Juliana Silvatti; Izabela N F de Almeida; Elise V Taniguchi; Tiago S Prata; Augusto Paranhos; Cristiane Kayser
Journal:  Int Ophthalmol       Date:  2021-11-25       Impact factor: 2.031

Review 5.  Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.

Authors:  Kate E Keller; Mary K Wirtz
Journal:  Exp Eye Res       Date:  2016-06-11       Impact factor: 3.467

6.  Ocular findings in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Priscilla Magalhães; Newton Kara-Junior; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Prevalence of ocular manifestations in systemic sclerosis patients.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Piotr Jurowski
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

8.  Evaluation of the optic nerve head vessel density in patients with limited scleroderma.

Authors:  Hilal Kılınç Hekimsoy; Ali Mehmet Şekeroğlu; Ali Mert Koçer; Vedat Hekimsoy; Ali Akdoğan
Journal:  Ther Adv Ophthalmol       Date:  2021-02-27

Review 9.  Ocular manifestations in patients with systemic sclerosis.

Authors:  Małgorzata Kozikowska; Wojciech Luboń; Eugeniusz J Kucharz; Ewa Mrukwa-Kominek
Journal:  Reumatologia       Date:  2020-12-23

10.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.